- Home
- DRIO vs DYAI Comparison
DRIO vs DYAI Comparison
Compare DRIO & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRIO
- DYAI
- Stock Information
- Founded
- DRIO 2011
- DYAI 1979
- Country
- DRIO United States
- DYAI United States
- Employees
- DRIO N/A
- DYAI N/A
- Industry
- DRIO Medical/Dental Instruments
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DRIO Health Care
- DYAI Health Care
- Exchange
- DRIO Nasdaq
- DYAI Nasdaq
- Market Cap
- DRIO 30.5M
- DYAI 28.3M
- IPO Year
- DRIO N/A
- DYAI 2004
- Fundamental
- Price
- DRIO $0.58
- DYAI $1.13
- Analyst Decision
- DRIO Strong Buy
- DYAI Strong Buy
- Analyst Count
- DRIO 2
- DYAI 1
- Target Price
- DRIO $2.50
- DYAI $6.00
- AVG Volume (30 Days)
- DRIO 175.1K
- DYAI 203.9K
- Earning Date
- DRIO 08-11-2025
- DYAI 08-12-2025
- Dividend Yield
- DRIO N/A
- DYAI N/A
- EPS Growth
- DRIO N/A
- DYAI N/A
- EPS
- DRIO N/A
- DYAI N/A
- Revenue
- DRIO $28,034,000.00
- DYAI $3,554,344.00
- Revenue This Year
- DRIO $20.85
- DYAI $22.56
- Revenue Next Year
- DRIO $17.09
- DYAI $30.95
- P/E Ratio
- DRIO N/A
- DYAI N/A
- Revenue Growth
- DRIO 47.20
- DYAI 57.59
- 52 Week Low
- DRIO $0.50
- DYAI $0.91
- 52 Week High
- DRIO $1.55
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- DRIO 31.86
- DYAI 62.78
- Support Level
- DRIO $0.52
- DYAI $1.08
- Resistance Level
- DRIO $0.74
- DYAI $1.20
- Average True Range (ATR)
- DRIO 0.05
- DYAI 0.08
- MACD
- DRIO -0.02
- DYAI 0.02
- Stochastic Oscillator
- DRIO 26.48
- DYAI 50.00
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.